Observational Study of Complications Related to Use of Peripherally Inserted Central Catheters
Completed
- Conditions
- Adult Patients With Peripherally Inserted Central Catheters
- Registration Number
- NCT01578993
- Lead Sponsor
- Teleflex
- Brief Summary
The purpose of this study is to determine the rate and timing of interventions and complications related to the use of peripherally inserted central venous catheters in adult patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 101
Inclusion Criteria
- Male or Female Age > 18 years requiring central venous access
- Ability to comply with study requirements
- Written Informed Consent
Exclusion Criteria
- Previous enrollment in study
- Current or recent upper extremity thrombosis, occlusion or stenosis
- Previous axillary lymph node dissection
- Skin inflammatory condition or rashes within 15 cm from insertion site
- Pre-existing history of hypercoagulability unrelated to malignant disease
- Participating in trial involving antithrombotic, anticoagulant or anti- infective drug therapies
- Positive blood culture within 48 hours from planned PICC placement
- Known, renal insufficiency with chronic creatinine levels > 1.7 mg/dl
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of PICC Line Occlusions Insertion to Removal / maximum 3 months The incidence, severity and management of PICC line occlusions were recorded for each of the enrolled subjects.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie PICC-related complications in adult patients as observed in NCT01578993?
How does PICC use compare to standard-of-care venous access in terms of complication rates and management strategies?
Are there specific biomarkers that identify adult patients at higher risk for PICC-related interventions or complications?
What are the most common adverse events associated with peripherally inserted central catheters in observational studies like NCT01578993?
How do PICC-related outcomes in NCT01578993 compare to other central venous catheter types in clinical practice guidelines?
Trial Locations
- Locations (1)
Ronald Reagan UCLA Medical Center
🇺🇸Los Angeles, California, United States
Ronald Reagan UCLA Medical Center🇺🇸Los Angeles, California, United States